Top
Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A
Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A
A retrospective 6 case series
DOI: 10.1097/MD.0000000000026587, Volume: 100, Issue: 29, Pages: 0-0
Article Type: research-article,
Article History
received:
rev-recd:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1097/MD.0000000000026587&title=Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A&author=&keyword=[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],[{keywordId=4254, uniqueName=combined-modality-therapy, name=Combined modality therapy, contentId=306075}, {keywordId=4550, uniqueName=dexamethasone, name=Dexamethasone, contentId=306075}, {keywordId=6941, uniqueName=corticosteroids, name=Corticosteroids, contentId=306075}, {keywordId=11079, uniqueName=rituximab, name=Rituximab, contentId=306075}, {keywordId=11081, uniqueName=immunosuppressive-agents, name=Immunosuppressive Agents, contentId=306075}, {keywordId=13702, uniqueName=methylprednisolone, name=Methylprednisolone, contentId=306075}, {keywordId=14746, uniqueName=plasma-exchange, name=plasma exchange, contentId=306075}, {keywordId=27671, uniqueName=hemophilia-a, name=Hemophilia A, contentId=306075}, {keywordId=67437, uniqueName=factor-viii-deficiency, name=factor VIII deficiency, contentId=306075}, {keywordId=229346, uniqueName=multimodal-treatment, last=true, name=Multimodal treatment, contentId=306075}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova